Objective To evaluate new classification criteria for peripheral spondyloarthritis (SpA) in
patients with SpA with peripheral manifestations only. Methods In this Assessment of …

To update and integrate the recommendations for ankylosing spondylitis and the recommendations
for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA…

Objectives To review and update the existing definition of a positive MRI for classification of
axial spondyloarthritis (SpA). Methods The Assessment in SpondyloArthritis International …

Objective To update the European League Against Rheumatism (EULAR) recommendations
for the pharmacological treatment of psoriatic arthritis (PsA). Methods According to the …

Background Since the publication of the European League Against Rheumatism recommendations
for the pharmacological treatment of psoriatic arthritis (PsA) in 2012, new evidence …

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-EULAR
recommendations for the management of axial spondyloarthritis (axSpA). Methods …

Objectives: To evaluate various validity aspects of four disease activity scores (ASDAS) for
ankylosing spondylitis (AS) in comparison with the Bath Ankylosing Spondylitis Disease …

Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in
2012, but the evidence for these recommendations was only of indirect nature. These …

Objective To confirm in a placebo‐controlled trial the safety and efficacy profile of infliximab
in short‐term treatment of patients with active spondylarthropathy (SpA). Methods Forty …

Objective. To compare the clinical efficacy and safety of leflunomide and methotrexate for the
treatment of rheumatoid arthritis (RA). Methods. In this multicentre, double‐blind trial, 999 …